2017-2022 United States Injectable Anticoagulants Market Report (Status and Outlook)

October 2017 | 115 pages | ID: 2BB57FC0C9CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In 2016, the Injectable Anticoagulants market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

In United States market, the top players include

• Sanofi
• Genentech (Roche)
• Boehringer Ingelheim
• Pfizer
• The Medicines Company
• Aspen
• Otsuka

Split by product types/category, covering

• Low-molecular-weight Heparin (LMWH)
• Direct Thrombin Inhibitor (DTI)
• Other

Split by applications/end use industries, covers

• VTE
• ACS/MI
• AF
• Other

Contents

1 INJECTABLE ANTICOAGULANTS MARKET OVERVIEW

1.1 Product Overview and Scope of Injectable Anticoagulants
1.2 Injectable Anticoagulants Market Segment by Types
  1.2.1 United States Injectable Anticoagulants Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Injectable Anticoagulants Sales Market Share by Types in 2016
  1.2.3 Low-molecular-weight Heparin (LMWH)
    1.2.3.1 Major Players of Low-molecular-weight Heparin (LMWH)
  1.2.4 Direct Thrombin Inhibitor (DTI)
    1.2.4.1 Major Players of Direct Thrombin Inhibitor (DTI)
  1.2.5 Other
    1.2.5.1 Major Players of Other
1.3 United States Injectable Anticoagulants Market Segment by Applications/End Use Industries
  1.3.1 United States Injectable Anticoagulants Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Injectable Anticoagulants Sales Market Share by Applications in 2016
  1.3.2 VTE
  1.3.3 ACS/MI
  1.3.4 AF
  1.3.5 Other
1.4 United States Injectable Anticoagulants Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Injectable Anticoagulants Overview
  1.4.2 United States Injectable Anticoagulants Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 United States Injectable Anticoagulants Sales and Market Share (2012-2017) by Players
2.2 United States Injectable Anticoagulants Revenue and Market Share by Players (2012-2017)
2.3 United States Injectable Anticoagulants Average Price by Players in 2016
2.4 United States Injectable Anticoagulants Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Injectable Anticoagulants Market Competitive Situation and Trends
  2.5.1 Injectable Anticoagulants Market Concentration Rate
  2.5.2 Injectable Anticoagulants Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES INJECTABLE ANTICOAGULANTS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Injectable Anticoagulants Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Injectable Anticoagulants Sales and Market Share by Type (2012-2017)
  3.1.2 United States Injectable Anticoagulants Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Injectable Anticoagulants Price by Type (2012-2017)
3.2 United States Injectable Anticoagulants Sales and Market Share by Application (2012-2017)
3.3 United States Market Injectable Anticoagulants Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES INJECTABLE ANTICOAGULANTS PLAYERS PROFILES AND SALES DATA

4.1 Sanofi
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Injectable Anticoagulants Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Sanofi News
4.2 Genentech (Roche)
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Injectable Anticoagulants Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Genentech (Roche) News
4.3 Boehringer Ingelheim
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Injectable Anticoagulants Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Boehringer Ingelheim News
4.4 Pfizer
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Injectable Anticoagulants Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Pfizer News
4.5 The Medicines Company
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Injectable Anticoagulants Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 The Medicines Company News
4.6 Aspen
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Injectable Anticoagulants Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Aspen News
4.7 Otsuka
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Injectable Anticoagulants Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Otsuka News

5 UNITED STATES INJECTABLE ANTICOAGULANTS MARKET FORECAST (2017-2022)

5.1 United States Injectable Anticoagulants Sales, Revenue and Price Forecast (2017-2022)
  5.1.1 United States Injectable Anticoagulants Sales and Growth Rate Forecast (2017-2022)
  5.1.2 United States Injectable Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
  5.1.3 United States Injectable Anticoagulants Price Trend Forecast (2017-2022)
5.2 United States Injectable Anticoagulants Sales Forecast by Type (2017-2022)
5.3 United States Injectable Anticoagulants Sales Forecast by Application (2017-2022)

6 PRODUCTION COST ANALYSIS OF INJECTABLE ANTICOAGULANTS

6.1 Main Raw Materials of Injectable Anticoagulants
  6.1.1 List of Injectable Anticoagulants Main Raw Materials
  6.1.2 Injectable Anticoagulants Main Raw Materials Price Analysis
  6.1.3 Injectable Anticoagulants Raw Materials Major Suppliers
  6.1.4 Injectable Anticoagulants Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Injectable Anticoagulants
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Production Expenses
6.3 Injectable Anticoagulants Manufacturing Process/Method

7 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

7.1 Injectable Anticoagulants Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Injectable Anticoagulants Major Players in 2016
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Sales Channel
  8.1.1 Direct Sales
  8.1.2 Indirect Sales
  8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Injectable Anticoagulants Distributors/Traders List in United States

9 MARKET INFLUENCES FACTORS ANALYSIS

9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Injectable Anticoagulants
Table Product Specifications of Injectable Anticoagulants
Figure United States Injectable Anticoagulants Sales (volume) for Each Type (2012-2022)
Figure United States Injectable Anticoagulants Sales Market Share by Types in 2016
Table Types of Injectable Anticoagulants
Figure Product Picture of Low-molecular-weight Heparin (LMWH)
Table Major Players of Low-molecular-weight Heparin (LMWH)
Figure Product Picture of Direct Thrombin Inhibitor (DTI)
Table Major Players of Direct Thrombin Inhibitor (DTI)
Figure Product Picture of Other
Table Major Players of Other
Figure United States Injectable Anticoagulants Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Injectable Anticoagulants Sales Market Share by Applications in 2016
Table Applications of Injectable Anticoagulants
Figure VTE Examples
Figure ACS/MI Examples
Figure AF Examples
Figure Other Examples
Figure United States Injectable Anticoagulants Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Injectable Anticoagulants Sales (Volume) Status and Forecast (2012-2022)
Table United States Injectable Anticoagulants Sales by Players (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share (%) by Players (2012-2017)
Figure United States Injectable Anticoagulants Sales Share by Players in 2016
Figure United States Injectable Anticoagulants Sales Share by Players in 2017
Table United States Injectable Anticoagulants Revenue (Million USD) by Players (2012-2017)
Table United States Injectable Anticoagulants Revenue Market Share (%) by Players (2012-2017)
Figure United States Injectable Anticoagulants Revenue Share by Players in 2016
Figure United States Injectable Anticoagulants Revenue Share by Players in 2017
Figure United States Injectable Anticoagulants Average Price by Players in 2016
Table United States Injectable Anticoagulants Manufacturing Base Distribution and Sales Area by Players
Table Players Injectable Anticoagulants Product Types
Figure Injectable Anticoagulants Market Share of Top 3 Players
Figure Injectable Anticoagulants Market Share of Top 5 Players
Table United States Injectable Anticoagulants Sales by Type (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Type (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Type 2016
Figure 2016 United States Injectable Anticoagulants Sales Market Share by Type
Table United States Injectable Anticoagulants Revenue (Million USD) by Type (2012-2017)
Table United States Injectable Anticoagulants Revenue Market Share by Type (2012-2017)
Figure United States Injectable Anticoagulants Revenue Market Share by Type 2016
Figure 2016 United States Injectable Anticoagulants Revenue Market Share by Type
Table United States Injectable Anticoagulants Price by Type (2012-2017)
Table United States Injectable Anticoagulants Sales by Application (2012-2017)
Table United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Injectable Anticoagulants Sales Market Share by Application (2012-2017)
Figure 2016 United States Injectable Anticoagulants Sales Market Share by Application
Table United States Market Injectable Anticoagulants Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Injectable Anticoagulants Market Share (2012-2017)
Table Genentech (Roche) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech (Roche) Injectable Anticoagulants Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Injectable Anticoagulants Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Injectable Anticoagulants Market Share (2012-2017)
Table The Medicines Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure The Medicines Company Injectable Anticoagulants Market Share (2012-2017)
Table Aspen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aspen Injectable Anticoagulants Market Share (2012-2017)
Table Otsuka Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Otsuka Injectable Anticoagulants Market Share (2012-2017)
Figure United States Injectable Anticoagulants Sales and Growth Rate Forecast (2017-2022)
Figure United States Injectable Anticoagulants Revenue and Growth Rate Forecast (2017-2022)
Figure United States Injectable Anticoagulants Price Trend Forecast (2017-2022)
Table United States Injectable Anticoagulants Sales Forecast by Type (2017-2022)
Figure United States Injectable Anticoagulants Sales Market Share Forecast by Type (2017-2022)
Figure United States Injectable Anticoagulants Sales Market Share Forecast by Type in 2022
Table United States Injectable Anticoagulants Sales Forecast by Application (2017-2022)
Figure United States Injectable Anticoagulants Sales Market Share Forecast by Application (2017-2022)
Figure United States Injectable Anticoagulants Sales Market Share Forecast by Application in 2022
Table Production Base and Market Concentration Rate of Raw Material
Figure Injectable Anticoagulants Main Raw Materials Price Trend
Table Injectable Anticoagulants Raw Materials Major Suppliers List
Figure Production Cost Structure of Injectable Anticoagulants
Figure Injectable Anticoagulants Manufacturing Process/Method
Figure Injectable Anticoagulants Value Chain Analysis
Table Raw Materials Sources of Injectable Anticoagulants Major Players in 2016
Table Major Buyers of Injectable Anticoagulants
Table Injectable Anticoagulants Distributors/Traders List in United States